DeepsonBio

a pioneering approach to treating alzheimer’s disease deepsonbio, founded in 2018 in south korea, is at the forefront of alzheimer’s disease and cognitive disorder treatments. leveraging the expertise of our biomedical engineering team and collaborating with top clinical institutions like seoul national university school of medicine, we are revolutionizing brain health. our core innovation is the m-lipus (multiple low intensity pliant ultrasound) technology, which uses ultrasound waves to enhance the brain’s lymphatic system (bls) to clear waste products. this groundbreaking approach has the potential to treat and prevent alzheimer’s disease and other cognitive disorders. in partnership with harvard medical school, we are developing ultrasonic medical devices that stimulate brain activity. our clinical trials have shown significant improvements in cognitive abilities and brain metabolism, indicating a major advancement in neurological treatments.